Table 3.
The Correlations Between Individual Serum Peroxidation Products and Clinical Features in Patients With AAA.
| Characterization | Indices | MDA (nmol/mL) | LPO (umol/L) | GSH-Px (pg/mL) |
|---|---|---|---|---|
| Basic statistics | ||||
| BMI | −0.040 | 0.037 | −0.009 | |
| HR, bmp | −0.132 | −0.014 | −0.051 | |
| Maximum diameter, mm | 0.238 | 0.050 | 0.137 | |
| Routine blood indexes, leukocyte | ||||
| WBC, ×109/L | 0.004 | −0.034 | 0.020 | |
| BA, ×109/L | −0.001 | −0.177 | −0.036 | |
| EO, ×109/L | 0.041 | −0.074 | −0.040 | |
| LY, ×109/L | 0.211 | −0.037 | 0.257a | |
| MO, ×109/L | 0.075 | −0.074 | 0.016 | |
| NE, ×109/L | −0.053 | −0.048 | −0.050 | |
| Routine blood indexes, erythrocyte | ||||
| RBC, ×1012/L | 0.118 | −0.244 | 0.127 | |
| HGB, g/L | 0.036 | −0.198 | 0.091 | |
| HCT, L/L | 0.082 | −0.251 | 0.115 | |
| MCH, pg | −0.168 | 0.061 | −0.067 | |
| MCHC, g/L | −0.169 | 0.045 | −0.068 | |
| MCV, fL | −0.108 | 0.037 | −0.038 | |
| RDW, % | −0.076 | 0.353a | −0.109 | |
| Routine blood indexes, thrombocyte | ||||
| PLT, ×109/L | 0.010 | 0.005 | 0.017 | |
| MPV, fL | −0.050 | −0.080 | −0.142 | |
| PCT, L/L | 0.029 | −0.185 | 0.027 | |
| PDW, 10GSD | −0.023 | −0.089 | −0.142 | |
| Liver function | ||||
| ALT, U/L | 0.027 | −0.153 | −0.023 | |
| AST, U/L | 0.280 | −0.091 | 0.252 | |
| ALB, g/L | 0.209 | −0.148 | 0.145 | |
| GGT, U/L | −0.182 | −0.135 | −0.127 | |
| ALP, U/L | −0.083 | −0.142 | −0.089 | |
| BChE, 1000U/L | 0.283 | -0.082 | 0.058 | |
| PA, mg/dL | −0.097 | −0.256 | −0.085 | |
| TP, g/L | 0.381a | −0.066 | 0.232 | |
| TBIL, μmol/L | 0.135 | −0.014 | 0.132 | |
| DBIL, μmol/L | 0.707 | −0.117 | 0.284 | |
| Renal function and serum electrolyte | ||||
| Crea, mmol/L | −0.027 | −.667a | 0.206 | |
| Urea, mmol/L | −0.148 | 0.035 | −0.086 | |
| FPG, mmol/L | 0.154 | −0.116 | 0.010 | |
| CYSC, mg/L | −0.230 | 0.077 | −0.205 | |
| Ca, mmol/L | 0.176 | −0.066 | 0.063 | |
| K, mmol/L | −0.021 | −0.021 | 0.038 | |
| CL, mmol/L | 0.110 | 0.109 | 0.049 | |
| Na, mmol/L | 0.132 | −0.019 | 0.034 | |
| P, mmol/L | −0.130 | 0.010 | −0.208 | |
| HCO3, mmol/L | 0.325 | −0.052 | 0.271 | |
| Serum lipid profile | ||||
| TC, mmol/L | −0.116 | 0.150 | −.348a | |
| TG, mmol/L | 0.177 | −0.159 | −0.203 | |
| LDL-C, mmol/L | −0.101 | 0.105 | −0.194 | |
| HDL-C, mmol/L | −0.257 | 0.203 | −0.150 | |
| Cardiovascular injury-related parameters | ||||
| CK, U/L | 0.063 | −0.198 | 0.121 | |
| LDH, U/L | 0.238 | −0.181 | 0.217 | |
| Blood coagulation function | ||||
| PT, s | −0.013 | 0.323a | −0.003 | |
| APTT, s | 0.137 | 0.230 | −0.019 | |
| PTA, s | −0.004 | −0.061 | −0.025 | |
| INR | −0.021 | 0.161 | −0.001 | |
| D-Dimer, μg/mL | −0.155 | 0.089 | −0.131 |
Abbreviations: AAA, abdominal aortic aneurysm; ALT, alanine aminotransferase; ALB, albumin; ALP, alkaline phosphatase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; BChE, cholinesterase; BA, basophil; BMI, body mass index; Ca, serum calcium; CK, creatine kinase; CL, serum chlorine; Crea, Creatinine; CYSC, Cystatin C; DBIL, direct bilirubin; EO, eosinophil; FPG, fasting plasma glucose; GSH-Px, glutathione peroxidase; GGT, gamma glutamyl transpeptidase; HCT, hematocrit; HDL-C, high-density lipoprotein-cholesterol; HGB, hemoglobin; HR, heart rate; INR, international normalized ratio; K, serum kalium; LDH, lactate dehydrogenase; LY, lymphocyte; LPO, lipid hydroperoxides; LDL-C, low-density lipoprotein-cholesterol; MO, monocyte; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MDA, malondialdehyde; MPV, mean platelet volume; Na, serum sodium; NE, neutrophil; RBC, red blood cells; RDW, red blood cell volume distribution width; P, serum phosphorus; PCT, platelet hematocrit; PDW, platelet distribution width; PLT, platelet; PA, pre-albumin; PT, prothrombin time; PTA, prothrombin activity; TP, total protein; TBIL, total bilirubin; Urea, Carbamide; TC, total cholesterol; TG, triglycerides; WBC, white blood cells.
a P < .05.